Colonial Trust’s Takeda Pharmaceutical TAK Stock Holding History

Colonial Trust’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-221	Closed	-$3.14K	–	1355
2024 Q3	$3.14K	Hold	221	–	–	﹤0.01%	952
2024 Q2	$2.86K	Hold	221	–	–	﹤0.01%	907
2024 Q1	$3.14K	Hold	221	–	–	﹤0.01%	884
2023 Q4	$3.14K	Hold	221	–	–	﹤0.01%	846
2023 Q3	$3.38K	Hold	221	–	–	﹤0.01%	833
2023 Q2	$3.47K	Hold	221	–	–	﹤0.01%	830
2023 Q1	$3.61K	Hold	221	–	–	﹤0.01%	789
2022 Q4	$3.45K	Buy	+221	New	+$3.09K	﹤0.01%	801

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Colonial Trust's TAK Position: Q4 2024 in Review

Colonial Trust sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 221 shares — an estimated $3.14K sold.

Colonial Trust first reported a position in TAK in Q4 2022 and held it in 8 quarters. The position peaked at $3.61K in Q1 2023. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Colonial Trust reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Colonial Trust sold 221 Takeda Pharmaceutical shares in Q4 2024, an estimated $3.14K.
Colonial Trust first reported a position in Takeda Pharmaceutical in Q4 2022 and held it in 8 quarters.
Colonial Trust's Takeda Pharmaceutical position peaked at $3.61K in Q1 2023.
299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Colonial Trust's 13F filing for Q4 2024, filed 14 Feb 2025.